Skip to main content
Top
Published in: Abdominal Radiology 11/2021

01-11-2021 | Ultrasound | Hepatobiliary

Assessment of chronic liver disease by multiparametric ultrasound: results from a private practice outpatient facility

Authors: Varun Aitharaju, Annalisa De Silvestri, Richard G. Barr

Published in: Abdominal Radiology | Issue 11/2021

Login to get access

Abstract

Purpose

To assess chronic liver disease (CLD) using multiparametric US in a private practice setting in a cohort of patients with increased skin-to-liver distance.

Methods

110 consecutive patients with increased skin-to-liver distance scheduled for US assessment of CLD were reviewed for study completion time, liver stiffness values (LS), attenuation imaging, and shear wave dispersion slope. The ROI was placed 2 cm below the liver capsule. The study included patients with NAFLD/NASH (68), hepatitis C (30), prior Fontan surgery (1), elevated liver function tests (5), alcohol abuse (3), hepatitis B (2), and primary biliary cirrhosis (1). IQR/M values were obtained. Comparison of less experienced sonographers (LES) and more experienced sonographers (MES) were evaluated through Student’s t test for independent data. Pearson coefficient r of correlation among quantitative variables was calculated.

Results

The mean time to perform the exam was 129.7 ± 62.1 s. There was a statistically significant difference between LES and MES. The mean IQR/M for LS was 12.3 ± 5.5% m/s. Overall, in a cohort of difficult patients, 4.5% of LS values were not reliable. Fat quantification using attenuation imaging had a mean value of 0.60 ± 0.15 dB/cm/MHz (range 0.35–0.98 cm/dB/MHz) with an IQR/M of 14.7 ± 9.2%. Less reliable measurements of steatosis were obtained in 4.5% of patients. The mean shear wave dispersion slope was 12.74 ± 4.05 (m/s)/kHz (range 7.7–27.5 (m/s)/kHz) with an IQR/M of 38.7 ± 20.2% (range 3–131%). 20.9% of patients had values suggestive of compensated advanced chronic liver disease (cACLD).

Conclusion

Multiparametric US can provide assessment of CLD in less than 3 min in most patients and identify patients at risk for cACLD.
Literature
1.
go back to reference Asrani, S.K., et al., Burden of liver diseases in the world. J Hepatol, 2019. 70(1): p. 151-171.CrossRef Asrani, S.K., et al., Burden of liver diseases in the world. J Hepatol, 2019. 70(1): p. 151-171.CrossRef
2.
go back to reference Younossi, Z.M., et al., Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology, 2016. 64(1): p. 73-84.CrossRef Younossi, Z.M., et al., Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology, 2016. 64(1): p. 73-84.CrossRef
3.
go back to reference European Association for the Study of the, L., D. European Association for the Study of, and O. European Association for the Study of, EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol, 2016. 64(6): p. 1388–402. European Association for the Study of the, L., D. European Association for the Study of, and O. European Association for the Study of, EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol, 2016. 64(6): p. 1388–402.
4.
go back to reference Chalasani, N., et al., The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology, 2018. 67(1): p. 328-357.CrossRef Chalasani, N., et al., The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology, 2018. 67(1): p. 328-357.CrossRef
5.
go back to reference Eslam, M., A.J. Sanyal, and J. George, Toward More Accurate Nomenclature for Fatty Liver Diseases. Gastroenterology, 2019. 157(3): p. 590-593.CrossRef Eslam, M., A.J. Sanyal, and J. George, Toward More Accurate Nomenclature for Fatty Liver Diseases. Gastroenterology, 2019. 157(3): p. 590-593.CrossRef
6.
go back to reference Barr, R.G., Shear wave liver elastography. Abdom Radiol (NY), 2018. 43(4): p. 800-807.CrossRef Barr, R.G., Shear wave liver elastography. Abdom Radiol (NY), 2018. 43(4): p. 800-807.CrossRef
7.
go back to reference Barr, R.G., et al., Elastography Assessment of Liver Fibrosis: Society of Radiologists in Ultrasound Consensus Conference Statement. Radiology, 2015. 276(3): p. 845-61.CrossRef Barr, R.G., et al., Elastography Assessment of Liver Fibrosis: Society of Radiologists in Ultrasound Consensus Conference Statement. Radiology, 2015. 276(3): p. 845-61.CrossRef
8.
go back to reference Lv, S., et al., Noninvasive Quantitative Detection Methods of Liver Fat Content in Nonalcoholic Fatty Liver Disease. J Clin Transl Hepatol, 2018. 6(2): p. 217-221.CrossRef Lv, S., et al., Noninvasive Quantitative Detection Methods of Liver Fat Content in Nonalcoholic Fatty Liver Disease. J Clin Transl Hepatol, 2018. 6(2): p. 217-221.CrossRef
9.
go back to reference Myers, R.P., A. Fong, and A.A. Shaheen, Utilization rates, complications and costs of percutaneous liver biopsy: a population-based study including 4275 biopsies. Liver Int, 2008. 28(5): p. 705-12.CrossRef Myers, R.P., A. Fong, and A.A. Shaheen, Utilization rates, complications and costs of percutaneous liver biopsy: a population-based study including 4275 biopsies. Liver Int, 2008. 28(5): p. 705-12.CrossRef
10.
go back to reference Smith, A.D., et al., Current Imaging Techniques for Noninvasive Staging of Hepatic Fibrosis. AJR Am J Roentgenol, 2019. 213(1): p. 77-89.CrossRef Smith, A.D., et al., Current Imaging Techniques for Noninvasive Staging of Hepatic Fibrosis. AJR Am J Roentgenol, 2019. 213(1): p. 77-89.CrossRef
11.
go back to reference Shiina, T., et al., WFUMB guidelines and recommendations for clinical use of ultrasound elastography: Part 1: basic principles and terminology. Ultrasound Med Biol, 2015. 41(5): p. 1126-47.CrossRef Shiina, T., et al., WFUMB guidelines and recommendations for clinical use of ultrasound elastography: Part 1: basic principles and terminology. Ultrasound Med Biol, 2015. 41(5): p. 1126-47.CrossRef
12.
go back to reference Loomba, R. and A.J. Sanyal, The global NAFLD epidemic. Nat Rev Gastroenterol Hepatol, 2013. 10(11): p. 686-90.CrossRef Loomba, R. and A.J. Sanyal, The global NAFLD epidemic. Nat Rev Gastroenterol Hepatol, 2013. 10(11): p. 686-90.CrossRef
13.
go back to reference Lee, D.H., et al., Accuracy of Two-Dimensional Shear Wave Elastography and Attenuation Imaging for Evaluation of Patients With Nonalcoholic Steatohepatitis. Clin Gastroenterol Hepatol, 2020. Lee, D.H., et al., Accuracy of Two-Dimensional Shear Wave Elastography and Attenuation Imaging for Evaluation of Patients With Nonalcoholic Steatohepatitis. Clin Gastroenterol Hepatol, 2020.
14.
go back to reference Kwon, E.Y., et al., Usefulness of US attenuation imaging for the detection and severity grading of hepatic steatosis in routine abdominal ultrasonography. Clin Imaging, 2021. 76: p. 53-59.CrossRef Kwon, E.Y., et al., Usefulness of US attenuation imaging for the detection and severity grading of hepatic steatosis in routine abdominal ultrasonography. Clin Imaging, 2021. 76: p. 53-59.CrossRef
15.
go back to reference Koizumi, Y., et al., New diagnostic technique to evaluate hepatic steatosis using the attenuation coefficient on ultrasound B mode. PLoS One, 2019. 14(8): p. e0221548. Koizumi, Y., et al., New diagnostic technique to evaluate hepatic steatosis using the attenuation coefficient on ultrasound B mode. PLoS One, 2019. 14(8): p. e0221548.
16.
go back to reference Zhang, Y.N., et al., Liver fat imaging-a clinical overview of ultrasound, CT, and MR imaging. Br J Radiol, 2018. 91(1089): p. 20170959.CrossRef Zhang, Y.N., et al., Liver fat imaging-a clinical overview of ultrasound, CT, and MR imaging. Br J Radiol, 2018. 91(1089): p. 20170959.CrossRef
17.
go back to reference Raptis, D.A., et al., MRI: the new reference standard in quantifying hepatic steatosis? Gut, 2012. 61(1): p. 117-27.CrossRef Raptis, D.A., et al., MRI: the new reference standard in quantifying hepatic steatosis? Gut, 2012. 61(1): p. 117-27.CrossRef
18.
go back to reference Ferraioli G, B.A., Barr RG, et. al, Quantification of Liver Fat Content with Ultrasound: A WFUMB Position Paper. UMB, 2021. in press. Ferraioli G, B.A., Barr RG, et. al, Quantification of Liver Fat Content with Ultrasound: A WFUMB Position Paper. UMB, 2021. in press.
19.
go back to reference Sugimoto, K., et al., The Role of Multiparametric US of the Liver for the Evaluation of Nonalcoholic Steatohepatitis. Radiology, 2020. 296(3): p. 532-540.CrossRef Sugimoto, K., et al., The Role of Multiparametric US of the Liver for the Evaluation of Nonalcoholic Steatohepatitis. Radiology, 2020. 296(3): p. 532-540.CrossRef
20.
go back to reference Lee, D.H., et al., Shear-Wave Dispersion Slope from US Shear-Wave Elastography: Detection of Allograft Damage after Liver Transplantation. Radiology, 2019. 293(2): p. 327-333.CrossRef Lee, D.H., et al., Shear-Wave Dispersion Slope from US Shear-Wave Elastography: Detection of Allograft Damage after Liver Transplantation. Radiology, 2019. 293(2): p. 327-333.CrossRef
21.
go back to reference Byenfeldt, M., A. Elvin, and P. Fransson, On Patient Related Factors and Their Impact on Ultrasound-Based Shear Wave Elastography of the Liver. Ultrasound Med Biol, 2018. 44(8): p. 1606-1615.CrossRef Byenfeldt, M., A. Elvin, and P. Fransson, On Patient Related Factors and Their Impact on Ultrasound-Based Shear Wave Elastography of the Liver. Ultrasound Med Biol, 2018. 44(8): p. 1606-1615.CrossRef
22.
go back to reference Barr, R.G., et al., Update to the Society of Radiologists in Ultrasound Liver Elastography Consensus Statement. Radiology, 2020. 296(2): p. 263-274.CrossRef Barr, R.G., et al., Update to the Society of Radiologists in Ultrasound Liver Elastography Consensus Statement. Radiology, 2020. 296(2): p. 263-274.CrossRef
23.
go back to reference Ferraioli, G., et al., Detection of Liver Steatosis With a Novel Ultrasound-Based Technique: A Pilot Study Using MRI-Derived Proton Density Fat Fraction as the Gold Standard. Clin Transl Gastroenterol, 2019. 10(10): p. e00081. Ferraioli, G., et al., Detection of Liver Steatosis With a Novel Ultrasound-Based Technique: A Pilot Study Using MRI-Derived Proton Density Fat Fraction as the Gold Standard. Clin Transl Gastroenterol, 2019. 10(10): p. e00081.
24.
go back to reference Ferraioli, G. and R.G. Barr, Ultrasound liver elastography beyond liver fibrosis assessment. World Journal of Gastroenterology, 2020. in press. Ferraioli, G. and R.G. Barr, Ultrasound liver elastography beyond liver fibrosis assessment. World Journal of Gastroenterology, 2020. in press.
25.
go back to reference Ferraioli, G., R.G. Barr, and J.R. Dillman, Elastography for Pediatric Chronic Liver Disease: A Review and Expert Opinion. J Ultrasound Med, 2020. Ferraioli, G., R.G. Barr, and J.R. Dillman, Elastography for Pediatric Chronic Liver Disease: A Review and Expert Opinion. J Ultrasound Med, 2020.
26.
go back to reference Ferraioli, G., et al., Evaluation of Inter-System Variability in Liver Stiffness Measurements. Ultraschall Med, 2019. 40(1): p. 64-75.CrossRef Ferraioli, G., et al., Evaluation of Inter-System Variability in Liver Stiffness Measurements. Ultraschall Med, 2019. 40(1): p. 64-75.CrossRef
27.
go back to reference Ferraioli, G., et al., Ruling-in and Ruling-out Significant Fibrosis and Cirrhosis in Patients with Chronic Hepatitis C Using a Shear Wave Measurement Method. J Gastrointestin Liver Dis, 2017. 26(2): p. 139-143.CrossRef Ferraioli, G., et al., Ruling-in and Ruling-out Significant Fibrosis and Cirrhosis in Patients with Chronic Hepatitis C Using a Shear Wave Measurement Method. J Gastrointestin Liver Dis, 2017. 26(2): p. 139-143.CrossRef
28.
go back to reference Ferraioli, G., et al., Liver Ultrasound Elastography: An Update to the World Federation for Ultrasound in Medicine and Biology Guidelines and Recommendations. Ultrasound Med Biol, 2018. 44(12): p. 2419-2440.CrossRef Ferraioli, G., et al., Liver Ultrasound Elastography: An Update to the World Federation for Ultrasound in Medicine and Biology Guidelines and Recommendations. Ultrasound Med Biol, 2018. 44(12): p. 2419-2440.CrossRef
29.
go back to reference Morishita, N., et al., Liver stiffness measurement by acoustic radiation force impulse is useful in predicting the presence of esophageal varices or high-risk esophageal varices among patients with HCV-related cirrhosis. J Gastroenterol, 2014. 49(7): p. 1175-82.CrossRef Morishita, N., et al., Liver stiffness measurement by acoustic radiation force impulse is useful in predicting the presence of esophageal varices or high-risk esophageal varices among patients with HCV-related cirrhosis. J Gastroenterol, 2014. 49(7): p. 1175-82.CrossRef
30.
go back to reference Park, Y., et al., A novel model to predict esophageal varices in patients with compensated cirrhosis using acoustic radiation force impulse elastography. PLoS One, 2015. 10(3): p. e0121009. Park, Y., et al., A novel model to predict esophageal varices in patients with compensated cirrhosis using acoustic radiation force impulse elastography. PLoS One, 2015. 10(3): p. e0121009.
31.
go back to reference Attia, D., et al., Evaluation of Liver and Spleen Stiffness with Acoustic Radiation Force Impulse Quantification Elastography for Diagnosing Clinically Significant Portal Hypertension. Ultraschall Med, 2015. 36(6): p. 603-10.CrossRef Attia, D., et al., Evaluation of Liver and Spleen Stiffness with Acoustic Radiation Force Impulse Quantification Elastography for Diagnosing Clinically Significant Portal Hypertension. Ultraschall Med, 2015. 36(6): p. 603-10.CrossRef
32.
go back to reference Jansen, C., et al., Algorithm to rule out clinically significant portal hypertension combining Shear-wave elastography of liver and spleen: a prospective multicentre study. Gut, 2016. 65(6): p. 1057-8.CrossRef Jansen, C., et al., Algorithm to rule out clinically significant portal hypertension combining Shear-wave elastography of liver and spleen: a prospective multicentre study. Gut, 2016. 65(6): p. 1057-8.CrossRef
33.
go back to reference Jeon, S.K., et al., Prospective Evaluation of Hepatic Steatosis Using Ultrasound Attenuation Imaging in Patients with Chronic Liver Disease with Magnetic Resonance Imaging Proton Density Fat Fraction as the Reference Standard. Ultrasound Med Biol, 2019. 45(6): p. 1407-1416.CrossRef Jeon, S.K., et al., Prospective Evaluation of Hepatic Steatosis Using Ultrasound Attenuation Imaging in Patients with Chronic Liver Disease with Magnetic Resonance Imaging Proton Density Fat Fraction as the Reference Standard. Ultrasound Med Biol, 2019. 45(6): p. 1407-1416.CrossRef
34.
go back to reference Yoo, J., et al., Reproducibility of ultrasound attenuation imaging for the noninvasive evaluation of hepatic steatosis. Ultrasonography, 2020. 39(2): p. 121-129.CrossRef Yoo, J., et al., Reproducibility of ultrasound attenuation imaging for the noninvasive evaluation of hepatic steatosis. Ultrasonography, 2020. 39(2): p. 121-129.CrossRef
35.
go back to reference Bae, J.S., et al., Assessment of hepatic steatosis by using attenuation imaging: a quantitative, easy-to-perform ultrasound technique. Eur Radiol, 2019. 29(12): p. 6499-6507.CrossRef Bae, J.S., et al., Assessment of hepatic steatosis by using attenuation imaging: a quantitative, easy-to-perform ultrasound technique. Eur Radiol, 2019. 29(12): p. 6499-6507.CrossRef
36.
go back to reference Dioguardi Burgio, M., et al., Quantification of hepatic steatosis with ultrasound: promising role of attenuation imaging coefficient in a biopsy-proven cohort. Eur Radiol, 2020. 30(4): p. 2293-2301.CrossRef Dioguardi Burgio, M., et al., Quantification of hepatic steatosis with ultrasound: promising role of attenuation imaging coefficient in a biopsy-proven cohort. Eur Radiol, 2020. 30(4): p. 2293-2301.CrossRef
37.
go back to reference Ferraioli, G., et al., Performance of the Attenuation Imaging Technology in the Detection of Liver Steatosis. J Ultrasound Med, 2020. Ferraioli, G., et al., Performance of the Attenuation Imaging Technology in the Detection of Liver Steatosis. J Ultrasound Med, 2020.
38.
go back to reference Tada, T., et al., Usefulness of Attenuation Imaging with an Ultrasound Scanner for the Evaluation of Hepatic Steatosis. Ultrasound Med Biol, 2019. 45(10): p. 2679-2687.CrossRef Tada, T., et al., Usefulness of Attenuation Imaging with an Ultrasound Scanner for the Evaluation of Hepatic Steatosis. Ultrasound Med Biol, 2019. 45(10): p. 2679-2687.CrossRef
39.
go back to reference Ferraioli, G., CAP for the detection of hepatic steatosis in clinical practice. Lancet Gastroenterol Hepatol, 2021. 6(3): p. 151-152.CrossRef Ferraioli, G., CAP for the detection of hepatic steatosis in clinical practice. Lancet Gastroenterol Hepatol, 2021. 6(3): p. 151-152.CrossRef
40.
go back to reference Lee, D.H., et al., Accuracy of Two-Dimensional Shear Wave Elastography and Attenuation Imaging for Evaluation of Patients With Nonalcoholic Steatohepatitis. Clin Gastroenterol Hepatol, 2021. 19(4): p. 797–805 e7. Lee, D.H., et al., Accuracy of Two-Dimensional Shear Wave Elastography and Attenuation Imaging for Evaluation of Patients With Nonalcoholic Steatohepatitis. Clin Gastroenterol Hepatol, 2021. 19(4): p. 797–805 e7.
41.
go back to reference Yoo, J., et al., Prospective Validation of Repeatability of Shear Wave Dispersion Imaging for Evaluation of Non-alcoholic Fatty Liver Disease. Ultrasound Med Biol, 2019. 45(10): p. 2688-2696.CrossRef Yoo, J., et al., Prospective Validation of Repeatability of Shear Wave Dispersion Imaging for Evaluation of Non-alcoholic Fatty Liver Disease. Ultrasound Med Biol, 2019. 45(10): p. 2688-2696.CrossRef
Metadata
Title
Assessment of chronic liver disease by multiparametric ultrasound: results from a private practice outpatient facility
Authors
Varun Aitharaju
Annalisa De Silvestri
Richard G. Barr
Publication date
01-11-2021
Publisher
Springer US
Published in
Abdominal Radiology / Issue 11/2021
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-021-03225-2

Other articles of this Issue 11/2021

Abdominal Radiology 11/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.